The consortium succeeded very well in co-creating the MedGUIDE system with their end-users and in releasing an entirely working system, ready to be engineered prior to its commercialisation. As mentioned by the reviewers: ” The envisaged and expected outcomes and impact have been very well achieved in terms of end-users’ involvement in all the project phases […]
On the 2nd of December, Materia Group held an event at its premises to demonstrate the MedGUIDE application to healthcare professionals and collect their feedback. Materia Group is an end-user partner and responsible for the evaluation phases in the MedGUIDE project. Four occupational therapists from the European University of Cyprus were involved in the presentation […]
[September – by Sotia Nicalaou from Materia Group] MedGUIDE project currently runs the 2nd and final field trial through which it is aimed to assess whether primary, secondary and tertiary users can integrate the MedGUIDE system into their daily life and routine and whether the system better support the caregivers and professionals in the care […]
[By Vlad Lazar from Distributed Systems Research Laboratory / Technical University of Cluj-Napoca – July 2019] MedGUIDE project addresses the management of polypharmacy in older adults with dementia thus the monitoring of drugs intake is an important aspect. In case of our target group it is also technical as the patient drugs intake self-reporting is […]
[ June 2019 Utrecht, by Yusra Al Mudhafar] The E-Learning incorporated in MedGUIDE is a ‘’guide’’ to dementia providing the user with information on symptoms, stadia, medication use and adherence to medication. It entails information about care technology and other support tools to enhance quality of daily living with dementia. The e-Learning is intended for […]
[By Sotia Nicolaou from Materia – April 2019 ] During February and March 2019 the 1st field trial for assessing the MedGUIDE system took place in the three end-user organisations (the Netherlands, Norway and Cyprus). The MedGUIDE system was first evaluated in a controlled and afterwards in a home setting environment. In Cyprus, 3 primary, […]
[By Bas Steunenberg from HogeSchool Utrect – March 2019 ] In the beginning of March we had a so called ‘’co-creation session’’ with the primary end-users that are involved in the MedGUIDE project. These were persons with mild to moderate cognitive problems, still living at independently at home and still self-managing their own medication intake. […]
[By Philipp Buluschek from Vigisense/Domosafety – March 2019 ] In a previous blog post we presented the type of data and activities of daily living that needed to be collected in order to follow medication side effects. Beside the data that is collected, some practical aspects are also of importance. In facts, the sensor system […]
In this blog, we shortly present the reflections which lead to the selection of a suitable sensor system for the MedGUIDE solution. The first selection criteria is, which data is required in order to identify medication side-effects. The table below shows a list of common side-effect in dementia drugs as well as behavior based measurable […]
[by Tudor Cioara, March 2019] To identify the polypharmacy side effects affecting the daily life activities of patients with dementia, we have addressed the following issues in our prototype implementation (see figure below): – the detection of significant behavioral deviations from the patient’s baseline out of daily life activities monitored; – the correlation of these […]